PubMed Health⌕ Search

PubMed · 9030056

Space charge evaluation in a plasma-source mass spectrograph.

Abstract

Space charge effects, and the matrix interferences they cause, are problems in inductively coupled plasma mass spectrometry (ICPMS). It has previously been observed that these deleterious space charge effects are not significantly present in sector-field instruments, a fact that has been attributed, but not demonstrated, to the high accelerating potentials they commonly employ. To examine the significance of space charge in our plasma-source mass spectrograph (which operates at only moderate accelerating potentials) and in other sector instruments, a graphite disk was placed approximately 7 cm behind the skimmer. An inductively coupled plasma was operated for 17 h while a 0.01 mM multielement solution was introduced. This disk was then analyzed by spatially resolved laser ablation ICP time-of-flight MS. Second vacuum-stage acceleration appears to be an important factor that governs the elemental distribution within the ion beam. The ion beam width at m/z 208 is one-third of its width at m/z 7 using an accelerating potential of 800 V; at an accelerating potential of 4000 V, the ion beam width does not vary with mass.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T W Burgoyne, G M Hieftje, R A Hites. 1997-02-01. Space charge evaluation in a plasma-source mass spectrograph.. https://doi.org/10.1021/ac960673t

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Structure-resolved virus-host interactomics by cross-linking mass spectrometry.

Viruses depend on host protein networks to replicate, assemble progeny, and spread between cells and organisms. Defining these virus-host protein interactions is challenging because they are highly dependent on infection stage, cell type, species, and because mechanistic interpretation requires information about structural interfaces and conformational states. Cross-linking mass spectrometry (XL-MS) addresses these challenges by adding a spatial and structural dimension to virus-host interactomics in native systems. In this review, we discuss how XL-MS has advanced from targeted analysis of viral protein complexes to structure-resolved mapping of virion architecture and infected-cell virus-host interactomes. We highlight how XL-MS complements AP-MS, cryo-EM/cryo-ET, quantitative proteomics, genetic perturbation, and structure prediction to connect physical proximity with molecular mechanisms. Finally, we discuss current limitations in sensitivity, chemical coverage, temporal resolution, and model interpretation, and outline how future quantitative and integrative XL-MS workflows may enable systems-level structural virology.

Mass Spectrometry↗

Community-driven advances in computational mass spectrometry: The perspective of EuBIC-MS members.

Advances in data acquisition, artificial intelligence, and integrative bioinformatics are driving the rapid evolution of computational mass spectrometry, and in turn, transforming modern proteomics, metabolomics, and lipidomics. These developments have greatly increased the scale and complexity of mass spectrometry data, underscoring the importance of evolving accurate, transparent, efficient and reproducible data processing workflows. Addressing these challenges requires collaborative innovation that brings together expertise in software engineering, statistics, and biology. The European Bioinformatics Community for Mass Spectrometry (EuBIC-MS), an initiative of the European Proteomics Association (EuPA), fosters a culture of open, community-driven development through its biennial Developers Meetings and Winter Schools. This commentary summarizes the scientific background and outcomes of the EuBIC-MS Developers Meeting 2025, which took place in Novacella, Italy. Three keynote presentations highlighted major frontiers in the field: deep proteome and phosphoproteome profiling, text mining for protein-protein interaction extraction, and scalable proteomics for AI-driven drug discovery. Seven community-selected hackathons addressed emerging challenges such as single-cell proteomics data analysis, FAIR metadata extraction, deep learning frameworks, R-Python interoperability, and DIA validation. Together, these efforts demonstrate the potential for scientific and technical innovation to arise from open collaboration, and highlight how community-driven initiatives can accelerate progress in computational mass spectrometry. SIGNIFICANCE: Modern proteomics increasingly depends on computational advances to translate complex, high-dimensional data into biological knowledge. The EuBIC-MS Developers Meeting 2025 exemplifies how community-driven collaboration can directly accelerate this process by bringing together experts from bioinformatics, statistics, and experimental proteomics to co-develop open, interoperable, and reproducible analytical tools. By fostering shared software frameworks, transparent benchmarking, and collaborative problem solving, the EuBIC-MS community helps ensure that technological innovation translates into reliable biological insights. This collaborative model strengthens the foundation for quantitative, system-level understanding of proteomes and establishes a sustainable path for integrating artificial intelligence and next-generation data acquisition into routine biological discovery. This commentary shows some current highlights in the field of computational mass spectrometry and community-based approaches undertaken during the most recent Developers Meeting to solve these challenges. The approaches discussed and initiated during the meeting - ranging from deep proteome profiling and phosphosite mapping to text mining, single-cell data analysis, and FAIR metadata extraction - address key bottlenecks that currently limit the biological interpretability and comparability of proteomics data.

Mass Spectrometry↗

Proteome-wide structural and interaction analysis using cross-linking mass spectrometry and its applications.

Deciphering the mechanisms of protein-protein interactions (PPIs) and protein structural changes within the native cellular environment is crucial for advancing drug discovery. In vivo chemical cross-linking coupled with mass spectrometry (XL-MS) captures weak, transient, and higher-order interactions that are often dysregulated under altered physiological conditions and remain challenging to detect using conventional methods. Applications of in vivo XL-MS range from targeted mapping of PPIs to large-scale identification of interactome networks within the cells. The integration of quantitative approaches further facilitates comparison across different physiological conditions. The recent incorporation of machine learning (ML) tools into XL-MS workflows is transforming the depth and efficiency of this technology. AI-driven algorithms now enable more accurate identification of cross-linked peptides and the mapping of interaction topologies. Furthermore, the synergistic coupling of in vivo XL-MS data with AI-assisted structural modeling platforms such as AlphaFold allows dynamic and high-throughput prediction of protein networks. This review discusses the broader applications of in vivo XL-MS in complex biological samples, ranging from organelles and cells to whole tissues, and highlights how AI integration is expanding structural biology toward a systems-level understanding of proteome architecture.

Mass Spectrometry↗